In contrast, multiple rodent pulmonary hypertension models demonstrate that GLP-1 receptor agonists, including exendin-4 and liraglutide, reduce vascular remodelling, inflammation, and ventricular hypertrophy via endothelial nitric oxide signalling and suppression of endothelin-1 pathways [68,69,72,73]
This led to years of mixed results in clinical studies until the advent of liposomal technology
Research suggests that GLP-1 agents exert direct cardioprotective effects through anti-inflammatory mechanisms and improved endothelial function
PT-141 is sold for laboratory research use only
4.9 Stars on Google & Yelp 4 Million Patients Treated Backed by Licensed Providers 4.9 Stars on Google & Yelp 4 Million Patients Treated Backed by Licensed Providers Most Popular Services How it works 1 Book Your Appointment Select a time that works for you at our clinic in Manhattan Beach or virtually